Marcel Soesan

1.4k total citations
23 papers, 912 citations indexed

About

Marcel Soesan is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Marcel Soesan has authored 23 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Marcel Soesan's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and Chemotherapy-related skin toxicity (3 papers). Marcel Soesan is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and Chemotherapy-related skin toxicity (3 papers). Marcel Soesan collaborates with scholars based in Netherlands, Italy and Qatar. Marcel Soesan's co-authors include Jan H.M. Schellens, Jos H. Beijnen, Hans‐Martin Otten, Martin H. Prins, Hugo Ten Cate, Maarten J. Deenen, Dick J. Richel, Annemieke Cats, Caroline M.P.W. Mandigers and Didier Meulendijks and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Marcel Soesan

23 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Soesan Netherlands 12 462 237 182 139 117 23 912
Anne Riddell United Kingdom 26 159 0.3× 184 0.8× 189 1.0× 81 0.6× 871 7.4× 68 1.7k
Nelly G. Adel United States 9 926 2.0× 159 0.7× 223 1.2× 245 1.8× 108 0.9× 27 1.4k
Karl Tornyos United States 10 163 0.4× 83 0.4× 212 1.2× 111 0.8× 204 1.7× 20 633
Mariasanta Napolitano Italy 22 69 0.1× 148 0.6× 195 1.1× 120 0.9× 711 6.1× 117 1.3k
Sung‐Hyun Kim South Korea 17 371 0.8× 213 0.9× 117 0.6× 223 1.6× 352 3.0× 105 1.0k
Silke Kenngott Germany 6 267 0.6× 49 0.2× 67 0.4× 56 0.4× 92 0.8× 10 601
Raymond Thertulien United States 15 562 1.2× 706 3.0× 141 0.8× 76 0.5× 1.1k 9.3× 33 1.4k
Irving B. Mink United States 14 143 0.3× 70 0.3× 162 0.9× 113 0.8× 167 1.4× 25 639
Hans‐Martin Otten Netherlands 13 123 0.3× 148 0.6× 595 3.3× 59 0.4× 324 2.8× 28 1.1k
R.J. Pegoraro South Africa 22 482 1.0× 362 1.5× 16 0.1× 37 0.3× 81 0.7× 52 1.4k

Countries citing papers authored by Marcel Soesan

Since Specialization
Citations

This map shows the geographic impact of Marcel Soesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Soesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Soesan more than expected).

Fields of papers citing papers by Marcel Soesan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Soesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Soesan. The network helps show where Marcel Soesan may publish in the future.

Co-authorship network of co-authors of Marcel Soesan

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Soesan. A scholar is included among the top collaborators of Marcel Soesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Soesan. Marcel Soesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Soesan, Marcel, et al.. (2022). The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer. Breast Cancer Research and Treatment. 195(3). 325–331. 2 indexed citations
3.
Soesan, Marcel, et al.. (2022). Concurrent chemo-endocrine treatment for early hormone-positive breast cancer: a no-go???. Breast Cancer Research and Treatment. 192(3). 485–489. 1 indexed citations
4.
Meulendijks, Didier, Linda M. Henricks, Bart Jacobs, et al.. (2017). Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity. British Journal of Cancer. 116(11). 1415–1424. 81 indexed citations
5.
Houtenbos, Ilse, Jan Paul de Boer, Aart Beeker, et al.. (2016). Diffuse large B-cell lymphoma with MYC gene rearrangements. European Journal of Cancer. 55. 140–146. 15 indexed citations
6.
Deenen, Maarten J., Didier Meulendijks, Annemieke Cats, et al.. (2015). Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis. Journal of Clinical Oncology. 34(3). 227–234. 232 indexed citations
7.
Deenen, Maarten J., Annemieke Cats, Caroline M.P.W. Mandigers, et al.. (2012). [Prevention of severe toxicity from capecitabine, 5-fluorouracil and tegafur by screening for DPD-deficiency].. PubMed. 156(48). A4934–A4934. 6 indexed citations
8.
Wissen, Matthijs Van, et al.. (2009). Unusual presentation of Lemierre's syndrome: two cases and a review. Blood Coagulation & Fibrinolysis. 20(6). 466–469. 4 indexed citations
9.
Soesan, Marcel, et al.. (2007). Endothelial damage of the internal carotid artery after chemoradiotherapy of the neck for a Hodgkin lymphoma. Thrombosis and Haemostasis. 97(2). 315–316. 3 indexed citations
10.
Bosch, Tessa M., Alwin D. R. Huitema, Valerie D. Doodeman, et al.. (2006). Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel. Clinical Cancer Research. 12(19). 5786–5793. 107 indexed citations
11.
Otten, Hans‐Martin, et al.. (2004). Symptomatic Venous Thromboembolism in Cancer Patients Treated With Chemotherapy. Archives of Internal Medicine. 164(2). 190–190. 6 indexed citations
12.
Otten, Hans‐Martin, et al.. (2004). Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.. PubMed. 164(2). 190–4. 194 indexed citations
13.
Bongard, H.J.G.D. van den, Ron A. A. Mathôt, Willem Boogerd, et al.. (2001). Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure. Cancer Chemotherapy and Pharmacology. 47(6). 537–540. 21 indexed citations
14.
Huijgen, Henk J., et al.. (2000). Magnesium Levels in Critically Ill Patients. American Journal of Clinical Pathology. 114(5). 688–695. 84 indexed citations
15.
Huitema, Alwin D. R., et al.. (1998). A dose-dependent delayed hypersensitivity reaction to acetaminophen after repeated acetaminophen intoxications. Human & Experimental Toxicology. 17(7). 406–408. 1 indexed citations
16.
Soesan, Marcel, et al.. (1996). Combined dapsone and clofazimine intoxication. Human & Experimental Toxicology. 15(8). 625–628. 3 indexed citations
17.
Soesan, Marcel, Piet A. Kager, Maurine A. Leverstein‐van Hall, & Johannes J. van Lieshout. (1993). Coincidental severe Plasmodium falciparum infection and disseminated candidiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 87(3). 288–289. 11 indexed citations
18.
Soesan, Marcel, Adriano Paccagnella, Vanna Chiarion‐Sileni, et al.. (1992). Extramedullary plasmacytoma: Clinical behaviour and response to treatment. Annals of Oncology. 3(1). 51–57. 55 indexed citations
19.
Paccagnella, Adriano, Vanna Chiarion‐Sileni, Marcel Soesan, et al.. (1991). Second and third responses to the same induction regimen in relapsing patients with multiple myeloma. Cancer. 68(5). 975–980. 12 indexed citations
20.
Brandes, Alba A., Marcel Soesan, & Mario V. Fiorentino. (1991). Medical treatment of high grade malignant gliomas in adults: an overview.. PubMed. 11(2). 719–27. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026